April 18, 2013
The Biotechnology Industry Organization (BIO) named Dr. Jay Keasling as the recipient of its 2013 George Washington Carver Award for innovation in industrial biotechnology.
April 17, 2013
The fifth annual edition of Scientific American Worldview explores ongoing challenges and opportunities in the biopharmaceutical industry, including the looming potential of an “innovation cliff.”
April 16, 2013
April 11, 2013
Forum to confront issues and roadblocks to finding treatments and cures.
April 9, 2013
“We could not be more excited to celebrate the 10th anniversary of BIO’s World Congress to highlight the growth of the industry, particularly in Canada,” said Brent Erickson, executive vice president for BIO’s Industrial & Environmental Section.
April 8, 2013
Strong Intellectual Property Protection Is Vital For The Life Sciences Industry.
April 5, 2013
BIO announced the companies confirmed to present at the 2013 BIO International Convention.
March 25, 2013
Thousands to gather in Chicago, April 22-25.
March 21, 2013
In statehouses around the country, lawmakers are beginning to address the complexities of cutting-edge biotech drugs and the regulatory issues related to the interchangeability of biosimilar medicines.
March 14, 2013
The BIO Alliance Zone and Translational Research Forum to be featured at the global event for biotechnology.
March 7, 2013
Forbes 30 Under 30: The Rising Stars Transforming Science and Healthcare – The Real Future of Biotech.
March 7, 2013
Global biofuel and renewable chemical company executives and managers developing strategies to further commercialization will speak in breakout sessions at BIO’s 10th annual World Congress on Industrial Biotechnology this June in Montreal, Canada.
March 4, 2013
The 2013 BIO International Convention will feature six diverse Super Sessions highlighting pressing industry topics such as the state of the industry, emerging R&D initiatives between public and private sectors,the future of biotechnology under the Affordable Care Act (ACA) and the future of deal-making and global innovation.
February 28, 2013
Forum to highlight new therapies and diagnosis for rare diseases, business models and partnering strategies for orphan drug products and commercialization of biologics for orphan indications and rare diseases
February 25, 2013
Recently BIO hosted the 15th annual BIO CEO & Investor Conference at the Waldorf Astoria in New York City. The conference is the largest investor conference focused on for established and emerging publicly traded and select private biotech companies.
February 21, 2013
The Biotechnology Industry Organization (BIO) announced its plenary session program for the 2013 World Congress on Industrial Biotechnology featuring biofuel and biobased product company executives, scientists and government officials from across the globe.
February 13, 2013
With one-third of all attendees international, the 2013 BIO International Convention will host a wide range of programming focused on new opportunities within emerging markets and strategies for growing the global biotech industry
February 12, 2013
From the 15th Annual BIO CEO & Investor Conference at the Waldorf Astoria Hotel in New York on February 12th, 2013.